Bridging Gaps in Pharma and Healthcare
PT Anvita Pharma Indonesia, formerly known as PT BrightGene Biomedical Indonesia, is dedicated to advancing the pharmaceutical landscape in Indonesia and Southeast Asia. Established in 2018, we proudly stand as Indonesia’s first privately owned Active Pharmaceutical Ingredient (API) company focused on small molecules. With our state-of-the-art GMP-certified facility we are committed to bridging the gap in local API production and supporting national resilience in healthcare.
Why Anvita?
The name “Anvita” is derived from Sanskrit and means “the one who bridges the gap,” symbolizing knowledge, understanding, and wisdom. Anvita embodies our mission to bridge production gaps in APIs and finished products within Indonesia, collaborating with partners across the region to enhance local capabilities and self-sufficiency.
Our Values
At Anvita, we are guided by core values that shape our approach to developing medicines that address essential medical needs and strengthen national healthcare resilience.
We believe in the power of partnerships. Whether within our team, with external industrial partners, or across the healthcare ecosystem, we work together to achieve great and impactful results.
Collaboration
Integrity
We uphold the highest ethical standards in every aspect of our work - from development to manufacturing and distribution - ensuring transparency and honesty in all our relationships.
Innovation and Dedication
Our passion for pushing the boundaries of small molecule medicines drives us to continuously innovate. We strive to meet the pressing healthcare needs of our region, adapting and evolving to stay at the forefront of pharmaceutical advancements.
Excellence
We are dedicated to achieving the highest standards of quality in our operations. Our commitment to excellence ensures the safety, efficacy, and reliability of every drug product we develop.
Accountability
We take responsibility for the outcomes we deliver to patients, partners, and stakeholders, maintaining transparency and reliability throughout the healthcare supply chain.